COVID-19 后综合征:哈萨克斯坦的发病率,生物标志物和临床模式
A Dosbayeva1, A Serikbayev1, A Sharapiyeva1
1NJSC "Semey Medical University", Semey Republic of Kazakhstan.
后COVID综合征 (PCS) 影响了近一半的COVID-19幸存者,高血压和糖尿病是常见的并发症. 性酸酶等生物标志物可能有助于诊断,而疫苗似乎可以降低PCS风险.
科学领域:
- 医学研究
- 传染性疾病
- 公共卫生
背景情况:
- 后COVID综合征 (PCS) 由于其多样化的症状和持久的健康影响而带来各种挑战.
- 识别风险因素和生物标志物对于早期诊断和有效管理PCS至关重要.
研究的目的:
- 确定阿巴伊地区COVID后综合征 (PCS) 的流行率,诊断标志物和临床特征.
主要方法:
- 一项对639名COVID-19幸存者的队列研究分析了临床数据,生物标志物和疫苗接种史.
- 后勤回归和集群分析确定了风险因素和PCS亚型.
主要成果:
- PCS的患病率为47%,与高血压和糖尿病的发病率较高有关.
- 性酸酶 (ALP) 和较低的血红素 (HCT) 和免疫球蛋白G (IgG) 水平与PCS有关.
- 疫苗接种显著降低了PCS发病率,并确定了四种不同的临床表型.
结论:
- PCS表现出需要多学科方法的异质表现.
- 生物标志物 (ALP,HCT,IgG) 显示出可用于PCS诊断的可能性.
- 疫苗接种对于缓解长期COVID-19并发症至关重要.
更多相关视频
06:29Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
Published on: May 25, 2022
08:25Polar Histogram Visualization of Acute Stress Disorder Scale Scores for Comprehensive Clinical Assessment
Published on: December 6, 2024
相关概念视频
Myocarditis II: Clinical Features and Diagnostic Tests
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Acute Kidney Injury III: Clinical Manifestations
Pericarditis II: Clinical Features and Diagnostic Tests
Chronic Kidney Disease II: Clinical Manifestations
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
